- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Mo | MariMed Inc.: MariMed Extends Series B Preferred Stock Obligation Through 2031, Strengthening Capital Structure | 32 | GlobeNewswire (Europe) | NORWOOD, Mass., March 02, 2026 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or "the Company") (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, announced today... ► Artikel lesen | |
| 11.02. | Marimed Inc: Marimed to release 2025 results March 11 | 2 | Stockwatch | ||
| 11.02. | MariMed Inc.: MariMed Announces Fourth Quarter and Full Year 2025 Earnings Date | 1 | GlobeNewswire (USA) | ||
| 05.02. | Marimed Inc: Marimed's Betty's Eddies launches Berry In Love Betty | 2 | Stockwatch | ||
| 22.01. | Marimed Inc: Marimed rolls out Vibations THC in Rhode Island | 3 | Stockwatch | ||
| 22.01. | MariMed Inc.: MariMed Launches Hemp-Derived THC Products Under its Vibations Brand in Rhode Island | 1 | GlobeNewswire (USA) | ||
| 19.12.25 | Marimed Inc: Marimed welcomes cannabis as Schedule 3 drug in U.S. | 2 | Stockwatch | ||
| 18.12.25 | MariMed Inc.: MariMed Statement on Historic Rescheduling of Cannabis | 127 | GlobeNewswire (Europe) | NORWOOD, Mass., Dec. 18, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator committed to improving lives every day, issued the following... ► Artikel lesen | |
| MARIMED Aktie jetzt für 0€ handeln | |||||
| 08.12.25 | MariMed Inc.: Veterans Healing Journey Becomes Soundtrack of Thrive Dispensaries | 2 | GlobeNewswire (USA) | ||
| 18.11.25 | Marimed Inc: Marimed adds winter cranberry orange Betty's chew | 2 | Stockwatch | ||
| 18.11.25 | MariMed Inc.: MariMed's Betty's Eddies Introduces New Limited-Edition Winter Seasonal Cranberry Orange Fruit Chew, Bundle Up Betty's | 1 | GlobeNewswire (USA) | ||
| 06.11.25 | MariMed GAAP EPS of -$0.01, revenue of $40.76M misses by $1.39M | 4 | Seeking Alpha | ||
| 06.11.25 | MARIMED INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 06.11.25 | MariMed outlines national brand expansion and hemp entry while maintaining positive cash flow | 1 | Seeking Alpha | ||
| 05.11.25 | MariMed Inc.: MariMed Reports Third Quarter 2025 Earnings | 74 | GlobeNewswire (Europe) | NORWOOD, Mass., Nov. 05, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed" or the "Company") (CSE: MRMD) (OTCQX: MRMD), a leading multi-state cannabis operator focused on improving lives every day... ► Artikel lesen | |
| 05.11.25 | MARIMED INC. - 8-K, Current Report | - | SEC Filings | ||
| 03.11.25 | MariMed Inc.: MariMed To Launch Hemp-Derived THC Products, Introducing Its Top-Selling Brands to New Markets and Customers | 1 | GlobeNewswire (USA) | ||
| 29.10.25 | Marimed Inc: Marimed exits Missouri market | 1 | Stockwatch | ||
| 28.10.25 | MariMed announces strategic exit from Missouri market | 1 | Seeking Alpha | ||
| 28.10.25 | MariMed Inc.: MariMed Announces Strategic Exit From Missouri Market | 159 | GlobeNewswire (Europe) | NORWOOD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- MariMed Inc. ("MariMed") (CSE: MRMD) (OTCQX: MRMD), a leading cannabis consumer packaged goods company and retailer, today announced that it has completed... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| AURORA CANNABIS | 3,150 | -1,25 % | Is Aurora Cannabis Stock Ready to 10X in the Next Pot Boom? | ||
| ABBVIE | 199,00 | -0,75 % | AbbVie Reports Positive Phase 3 Results For Risankizumab In Crohn's Disease | WASHINGTON (dpa-AFX) - AbbVie (ABBV) on Monday announced positive results from the Phase 3 AFFIRM study evaluating subcutaneous risankizumab in moderately to severely active Crohn's disease.... ► Artikel lesen | |
| CANOPY GROWTH | 0,912 | -1,83 % | Is It Time to Dump Your Shares of Canopy Growth?? | ||
| TILRAY BRANDS | 6,390 | -1,84 % | MDMA-Herausforderer Bioxyne punktet mit 112% Umsatzplus. Und was macht Tilray? | ||
| INNOCAN PHARMA | 4,280 | +2,88 % | Innocan Pharma Corporation: FDA Center for Veterinary Medicine Grants Innocan a Fee Waiver in 2026 for the Third Consecutive Time | HERZLIYA, Israel and CALGARY, AB, Feb. 27, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (FSE: IP40) (OTCQB: INNPD) ("Innocan" or the "Company"),... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| DERMAPHARM | 38,200 | -3,66 % | Dermapharm: Spannend für langfristig orientierte Investoren | Am 17. März wird Dermapharm Zahlen für 2025 präsentieren. Erwartet wird von Dermapharm ein Umsatz von 1,16 Milliarden Euro bis 1,2 Milliarden Euro. Das bereinigte EBITDA sieht die Gesellschaft bei 322... ► Artikel lesen | |
| CRONOS GROUP | 2,294 | +1,77 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| SYNBIOTIC | 2,320 | -0,64 % | EQS-News: SYNBIOTIC SE: Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC | EQS-News: SYNBIOTIC SE
/ Schlagwort(e): Marktbericht/Sonstiges
Globale Dynamik im Cannabismarkt: Neue Signale aus den USA stärken langfristige Perspektiven für Europa und SYNBIOTIC... ► Artikel lesen | |
| DIGICANN VENTURES | 0,006 | -8,33 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,180 | +3,51 % | Organigram Global Inc: Organigram launches Edison, Boxhot in Australia | ||
| GREEN THUMB INDUSTRIES | 5,335 | -1,57 % | Green Thumb Industries Reports Fourth Quarter and Full Year 2025 Results | CHICAGO and VANCOUVER, British Columbia, Feb. 25, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,274 | -1,55 % | 1CM Inc.: SNDL & 1CM Complete Purchase and Sale of 5 Retail Stores in Alberta and Saskatchewan | Edmonton, Alberta and Toronto, Ontario--(Newsfile Corp. - January 7, 2026) - SNDL Inc. (NASDAQ: SNDL) (CSE: SNDL) ("SNDL") and 1CM Inc. (CSE: EPIC) (OTCQB: MILFF) (FSE: IQ70) ("1CM") are pleased... ► Artikel lesen | |
| CRESCO LABS | 0,823 | +3,92 % | Cresco Labs to Report Fourth Quarter 2025 Financial Results on March 5, 2026 | Cresco Labs Inc. (CSE:CL) (OTCQX:CRLBF) (FSE: 6CQ) ("Cresco" or "Company"), the industry leader in branded cannabis products with a portfolio of America's most popular brands and the operator of... ► Artikel lesen | |
| NOVERIS HEALTH SCIENCES | 0,076 | +51,20 % | JJK Holdings Ltd. Acquires $7,878,792 Convertible Debenture Of Noveris Health Sciences Inc.; Filing Of Early Warning Reports By JJK Holdings Ltd. And Pioneer Garage Limited |
MARIMED INC gehört der Branche Pharma an.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MARIMED INC finden Sie auf Wallstreet Online.